27. In regulation 36 [F1—
(a) in paragraph (4)—.
(i)for “The requirements” substitute “Where a manufacturer’s licence relates to the manufacture or assembly of a medicinal product in, or import of a medicinal product into, Northern Ireland, the requirements”;
(ii)for “provisions of a manufacturer’s” substitute “provisions of that”;
(b) in paragraph (6), after “by way of wholesale dealing” insert “in Northern Ireland”.]
Textual Amendments
F1Reg. 27(a)(b) substituted for words (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 17
Commencement Information
I1Reg. 27 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1